This addendum is intended to provide practical guidance for the preparation of periodicsafety update reports (PSURs) as recommended in the ICH guidance E2C Clinical SafetyData Management: Periodic Safety Update Reports for Marketed Drugs, which wasendorsed by the ICH in November 1996 and published by the FDA in May 1997. The E2Cguidance has been implemented in some but not all ICH countries.